Feedback / Questions
AX-158 - Artax Biopharma
https://www.prnewswire.com/news-releases/artax-announces-first-patient-dosed-in-phase-2a-psoriasis-trial-evaluating-ax-158-302060157.html
Feb 13, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next